CD8A and breast carcinoma: In breast cancer patients, increased intratumoral CD8 + T cell levels have been correlated with improved treatment outcomes, reinforcing the role of CD8 + T cell-mediated immunity in the efficacy of anthracycline chemotherapy (64).